查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2133899

2034年醫療影像和人工智慧診斷市場預測：按成像方法、人工智慧能力、部署模式、應用、最終用戶和地區分類的全球分析

Medical Imaging & AI-Enhanced Diagnostics Market Forecasts to 2034 - Global Analysis By Imaging Modality, AI Functionality, Deployment Model, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球醫學影像和人工智慧診斷市場規模將達到 33 億美元，在預測期內以 36.0% 的複合年成長率成長，到 2034 年將達到 386 億美元。

醫學影像和人工智慧輔助診斷透過將先進的影像系統與人工智慧相結合，提高了疾病識別率、診斷準確性和治療方案製定效率。人工智慧工具能夠評估X光、CT掃描、MRI掃描、超音波影像和其他診斷影像，識別異常情況，早期發現疾病，並輔助醫療專業人員。機器學習和深度學習技術實現了自動解讀、模式檢測和基於影像的測量。醫療數位化進程的推進、診斷影像處理工作量的增加、精準醫療的日益普及以及人工智慧的持續創新，正推動著這些解決方案在醫院、診斷檢查室、影像中心和其他醫療機構的廣泛應用。

根據美國食品藥物管理局（FDA）預測，到2024/2025年，將有超過1000種人工智慧/機器學習（AI/ML）醫療設備獲得批准，這表明受臨床監管的人工智慧技術在醫療領域正迅速擴張。在這些核准應用中，醫學影像和放射學領域佔了很大比例。

對早期準確疾病檢測的需求日益成長。

對更快、更精準的疾病識別的需求日益成長，正顯著推動醫學影像和人工智慧診斷市場的發展。人工智慧影像技術能夠幫助醫療專業人員更早發現異常情況和疾病徵兆，從而加速診斷和治療方案的發展。先進的深度學習系統可以處理海量醫學影像，識別複雜的模式，並突出顯示傳統影像難以識別的觀察。慢性病負擔的加重、老齡人口的成長以及診斷影像檢查使用量的增加，正迫使醫院和放射科採用基於人工智慧的解決方案，以提高工作流程效率、診斷可靠性和臨床決策能力。

高昂的實施成本和基礎設施需求

巨額投資需求和基礎設施挑戰可能會阻礙醫療影像和人工智慧診斷市場的擴張。人工智慧影像解決方案可能需要高效能運算系統、專用應用程式、安全的資料基礎設施以及與現有醫療技術的整合。醫院和診斷機構還需要投入資源用於設備現代化改造、網路安全措施、員工培訓、軟體更新和持續維護。此外，將人工智慧平台與傳統影像設備和電子健康記錄整合可能會增加技術複雜性、延長部署時間並提高成本，從而可能減緩其在市場上的廣泛應用。

人工智慧影像診斷技術在新興醫療市場的擴展

新興醫療市場對人工智慧（AI）影像技術的日益普及，為醫學影像和AI增強診斷市場創造了巨大的成長機會。在開發中國家，加強數位醫療基礎設施建設、升級診斷設備以及實施先進的臨床解決方案，正在推動診斷能力的提升。不斷上漲的醫療成本、醫院現代化、對診斷成像需求的成長以及政府支持的數位醫療項目，正促使技術提供商向服務不足的地區以及整個快速發展的醫療市場提供擴充性的AI成像解決方案。

誤診風險和演算法偏差

人工智慧系統潛在的診斷誤差和偏差對醫學影像和人工智慧輔助診斷市場構成重大威脅。使用狹窄或不一致的資料集開發的演算法，其結果可能因病患小組、成像技術和醫療環境的不同而存在差異。醫學影像的錯誤分類會導致漏診和不必要的警報，從而影響臨床結果，並可能削弱人們對人工智慧解決方案的信心。影像品質、設備和診斷程序方面的差異也會影響效能。因此，在人工智慧廣泛部署之前，醫療機構可能需要更嚴格的醫生監督、徹底的檢驗、持續的監測以及頻繁的演算法更新。

新型冠狀病毒（COVID-19）的影響：

新冠疫情危機對醫學影像和人工智慧診斷市場產生了積極和消極的雙重影響。初期，由於醫療機構集中精力治療感染患者和控制病毒傳播，常規和選擇性影像檢查大幅減少。同時，疫情加速了遠距放射學、人工智慧（AI）影像解讀和自動化診斷流程的普及應用。針對新冠病毒篩檢、分診和監測的人工智慧應用研究也取得了進展。疫情過後，隨著延期檢查的進行，影像檢查的需求顯著增加，醫療機構也越來越傾向於尋求高效的人工智慧解決方案來管理其診斷工作量。

在預測期內，電腦斷層掃描（CT）領域預計將佔據最大的市場佔有率。

在預測期內，電腦斷層掃描（CT）領域預計將佔據最大的市場佔有率。由於CT能夠快速提供清晰的影像，因此廣泛應用於急診醫學、癌症診斷、神經系統評估、心血管疾病治療和創傷管理等領域。人工智慧的引入透過自動重建、異常識別、影像分割、分診和定量評估功能，顯著提升了CT的工作流程。 CT的高臨床效用、龐大的影像工作量、成熟的診斷流程以及人工智慧整合CT技術的日益普及，共同鞏固了CT領域在人工智慧增強型醫學影像和診斷應用領域的主導地位。

預計在預測期內，診斷影像中心細分市場將呈現最高的複合年成長率。

在預測期內，診斷影像中心領域預計將呈現最高的成長率。隨著影像檢查工作量的不斷增加，這些機構正擴大採用人工智慧技術來簡化工作流程、加快報告速度並提高異常檢測能力。人工智慧工具能夠實現常規流程的自動化、為放射科醫生提供支援、優先處理緊急檢查並提高整體營運效率。門診影像服務的擴展和競爭壓力也促使診斷中心投資先進技術。因此，人工智慧驅動的影像和報告解決方案的廣泛應用預計將加速該領域的成長。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率。其領先地位得益於完善的醫療保健體系、先進的影像基礎設施以及人工智慧在診斷實踐中日益廣泛的應用。龐大的影像工作量、醫療技術投入以及強大的研發能力，正推動人工智慧解決方案的持續普及。該地區也聚集了許多成熟的影像公司和專業的AI技術供應商，加上有利的監管環境，這些因素共同推動了市場的發展。對更快診斷、更最佳化的放射科工作流程以及技術輔助臨床決策日益成長的需求，進一步鞏固了北美在市場上的主導地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率。醫療系統的快速現代化、診斷基礎設施的擴張以及人工智慧在醫學影像領域的進一步融合，正推動該地區的強勁成長。對診斷服務的需求不斷成長、醫療支出持續攀升以及熟練專科醫生的短缺，促使醫療機構採用人工智慧驅動的影像技術。中國、印度、日本和韓國是領先的成長市場。持續推進的數位化醫療項目、技術創新、醫療服務可近性的提升以及對人工智慧和影像基礎設施投資的增加，預計將繼續支撐該地區的成長。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域分類
    • 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰和機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章：全球醫學影像與人工智慧診斷市場：按影像模式分類

  • X光影像
  • 電腦斷層掃描（CT）
  • 磁振造影（MRI）
  • 超音波影像
  • 正子斷層掃描（PET）
  • 單光子發射電腦斷層掃描（SPECT）
  • 混合成像

第6章：全球醫學影像與人工智慧診斷市場：按人工智慧功能分類

  • 影像擷取最佳化
  • 影像重建和影像校正
  • 電腦輔助檢測（CAD）
  • 電腦輔助診斷（CADx）
  • 工作流程自動化與分診
  • 預測分析與風險分層
  • 臨床決策支援系統

第7章：全球醫學影像與人工智慧診斷市場：依部署模式分類

  • 本地部署解決方案
  • 基於雲端的解決方案
  • 混合實現

第8章：全球醫學影像與人工智慧診斷市場：按應用領域分類

  • 腫瘤學
  • 循環系統
  • 神經病學
  • 整形外科
  • 胃腸病學
  • 呼吸內科
  • 婦產科
  • 一般放射診斷

第9章：全球醫學影像和人工智慧診斷市場：按最終用戶分類

  • 醫院和診所
  • 診斷影像中心
  • 研究和學術機構
  • 製藥和生物技術公司

第10章：全球醫學影像與人工智慧診斷市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第11章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第12章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第13章：公司簡介

  • GE HealthCare
  • Siemens Healthineers
  • Koninklijke Philips NV
  • Canon Medical Systems
  • Fujifilm Holdings Corporation
  • Hologic, Inc.
  • Samsung Medison
  • Bracco Imaging SpA
  • Aidoc
  • Qure.ai
  • Viz.ai
  • Lunit Inc.
  • Tempus Labs
  • HeartFlow, Inc.
  • Enlitic, Inc.
  • Nanox.AI
  • Butterfly Network, Inc.
  • Riverain Technologies
Product Code: SMRC39635

According to Stratistics MRC, the Global Medical Imaging & AI-Enhanced Diagnostics Market is accounted for $3.3 billion in 2026 and is expected to reach $38.6 billion by 2034 growing at a CAGR of 36.0% during the forecast period. Medical Imaging & AI-Enhanced Diagnostics integrates sophisticated imaging systems with artificial intelligence to strengthen disease identification, diagnostic accuracy, and treatment decisions. AI-powered tools evaluate X-rays, CT, MRI, ultrasound, and other diagnostic images to recognize abnormalities, identify diseases at earlier stages, and assist medical professionals. Machine learning and deep learning technologies facilitate automated interpretation, pattern detection, and image-based measurements. Increasing healthcare digitization, rising diagnostic imaging workloads, growing emphasis on precision medicine, and continuous AI innovation are supporting wider adoption of these solutions among hospitals, diagnostic laboratories, imaging centers, and other healthcare providers.

According to the U.S. FDA, more than 1,000 AI/ML-enabled medical devices had been authorized by 2024/2025, demonstrating the rapid expansion of clinically regulated AI technologies in healthcare. Medical imaging and radiology represent a major portion of these authorized applications.

Market Dynamics:

Driver:

Growing demand for early and accurate disease detection

Increasing demand for faster and more precise disease identification is significantly supporting the Medical Imaging & AI-Enhanced Diagnostics Market. AI-enabled imaging technologies help healthcare professionals detect abnormalities and disease indicators earlier, enabling quicker diagnosis and treatment planning. Advanced deep learning systems can process large volumes of medical images, identify intricate patterns, and highlight findings that could be challenging to recognize through conventional interpretation. The growing burden of chronic illnesses, expanding elderly populations, and rising use of diagnostic imaging are prompting hospitals and imaging facilities to implement AI-based solutions that enhance workflow efficiency, diagnostic reliability, and clinical decision-making.

Restraint:

High implementation costs and infrastructure requirements

Significant investment requirements and infrastructure challenges can limit expansion of the Medical Imaging & AI-Enhanced Diagnostics Market. AI-powered imaging solutions may require high-performance computing systems, specialized applications, secure data infrastructure, and integration with established healthcare technologies. Hospitals and diagnostic facilities must also allocate resources for equipment modernization, cybersecurity measures, employee training, software updates, and ongoing maintenance. Furthermore, connecting AI platforms with legacy imaging equipment and electronic health records can create technical complexities, prolong implementation, and increase costs, potentially delaying broader market adoption.

Opportunity:

Expansion of AI-powered imaging in emerging healthcare markets

Increasing deployment of artificial intelligence-based imaging technologies in emerging healthcare markets creates substantial growth opportunities for the Medical Imaging & AI-Enhanced Diagnostics Market. Developing countries are strengthening digital healthcare infrastructure, upgrading diagnostic equipment, and adopting advanced clinical solutions to expand diagnostic capabilities. Rising healthcare spending, modernization of hospitals, growing demand for diagnostic imaging, and government-supported digital health programs are encouraging technology providers to deliver scalable AI imaging solutions throughout underserved and rapidly developing healthcare markets.

Threat:

Risk of diagnostic errors and algorithm bias

Potential diagnostic inaccuracies and biases in artificial intelligence systems pose an important threat to the Medical Imaging & AI-Enhanced Diagnostics Market. Algorithms developed using narrow or insufficiently diverse datasets may produce inconsistent results across different patient groups, imaging technologies, and healthcare settings. Misclassification of medical images can contribute to missed conditions or unnecessary alerts, potentially affecting clinical outcomes and reducing confidence in AI solutions. Differences in image quality, equipment, and diagnostic procedures can also impact performance. Consequently, healthcare providers may require greater physician supervision, extensive validation, ongoing monitoring, and frequent algorithm updates before widespread implementation.

Covid-19 Impact:

The COVID-19 crisis produced both negative and positive effects on the Medical Imaging & AI-Enhanced Diagnostics Market. Initially, routine examinations and elective imaging procedures decreased considerably as healthcare facilities concentrated on treating infected patients and limiting transmission. At the same time, the crisis encouraged faster adoption of remote radiology, artificial intelligence-based image interpretation, and automated diagnostic processes. AI applications were investigated for COVID-19 screening, triage, and monitoring. Following the pandemic, postponed examinations created substantial imaging demand, while healthcare providers increasingly sought efficient AI-supported solutions to manage diagnostic workloads.

The computed tomography (CT) segment is expected to be the largest during the forecast period

The computed tomography (CT) segment is expected to account for the largest market share during the forecast period. CT has broad applications in emergency medicine, cancer diagnosis, neurological evaluation, cardiovascular care, and trauma management because it delivers detailed images rapidly. The incorporation of AI enhances CT workflows through automated reconstruction, abnormality identification, image segmentation, triage, and quantitative assessment. Strong clinical utility, substantial imaging workloads, established diagnostic processes, and increasing adoption of AI-integrated CT technologies are supporting the segment's leading position within AI-enhanced medical imaging and diagnostic applications.

The diagnostic imaging centers segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the diagnostic imaging centers segment is predicted to witness the highest growth rate. Increasing imaging workloads are encouraging these facilities to deploy AI technologies for streamlined workflows, faster reporting, and enhanced abnormality detection. AI tools can automate routine processes, assist radiologists, prioritize urgent examinations, and improve operational efficiency. The expansion of outpatient imaging services and competitive pressure are also motivating diagnostic centers to invest in advanced technologies. Consequently, broader adoption of AI-supported imaging and reporting solutions is expected to accelerate segment growth.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share. Its dominance is supported by well-developed healthcare systems, advanced imaging infrastructure, and increasing integration of artificial intelligence into diagnostic practices. Significant imaging workloads, healthcare technology spending, and strong research capabilities encourage continued adoption of AI-based solutions. The region also has a large concentration of established imaging companies and specialized AI technology providers, alongside supportive regulatory developments. Growing requirements for faster diagnosis, improved radiology workflows, and technology-assisted clinical decisions are further contributing to North America's leading market position.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. Rapid modernization of healthcare systems, expanding diagnostic infrastructure, and greater integration of AI into medical imaging are supporting strong regional growth. Increasing demand for diagnostic services, higher healthcare spending, and limited availability of skilled specialists are motivating healthcare organizations to adopt AI-powered imaging technologies. China, India, Japan, and South Korea are key growth markets. Continued digital-health programs, technological innovation, improving healthcare accessibility, and rising investments in artificial intelligence and imaging infrastructure are expected to sustain regional expansion.

Key players in the market

Some of the key players in Medical Imaging & AI-Enhanced Diagnostics Market include GE HealthCare, Siemens Healthineers, Koninklijke Philips N.V., Canon Medical Systems, Fujifilm Holdings Corporation, Hologic, Inc., Samsung Medison, Bracco Imaging S.p.A., Aidoc, Qure.ai, Viz.ai, Lunit Inc., Tempus Labs, HeartFlow, Inc., Enlitic, Inc., Nanox.AI, Butterfly Network, Inc. and Riverain Technologies.

Key Developments:

In April 2026, GE HealthCare announced an expanded collaboration with DeepHealth, Inc, to further the innovation, commercialization, and adoption of advanced AI-powered mammography tools. The announcement coincides with the Society of Breast Imaging (SBI) Annual Symposium, where GE HealthCare will showcase its latest advancements in breast imaging and women's health.

In February 2026, Siemens Healthineers and Mayo Clinic are expanding their strategic collaboration to enhance patient care for neurodegenerative disease and the management of prostate cancer and metastatic liver tumors. The two organizations have signed an agreement that will improve care for those disease states and expand access to new imaging and interventional technologies.

Imaging Modalities Covered:

  • X-Ray Imaging
  • Computed Tomography (CT)
  • Magnetic Resonance Imaging (MRI)
  • Ultrasound Imaging
  • Positron Emission Tomography (PET)
  • Single Photon Emission Computed Tomography (SPECT)
  • Hybrid Imaging

AI Functionalities Covered:

  • Image Acquisition Optimization
  • Image Reconstruction & Enhancement
  • Computer-Aided Detection (CAD)
  • Computer-Aided Diagnosis (CADx)
  • Workflow Automation & Triage
  • Predictive Analytics & Risk Stratification
  • Clinical Decision Support Systems

Deployment Models Covered:

  • On-Premise Solutions
  • Cloud-Based Solutions
  • Hybrid Deployment

Applications Covered:

  • Oncology
  • Cardiology
  • Neurology
  • Orthopedics
  • Gastroenterology
  • Pulmonology
  • Obstetrics & Gynecology
  • General Radiology

End Users Covered:

  • Hospitals & Clinics
  • Diagnostic Imaging Centers
  • Research & Academic Institutes
  • Pharmaceutical & Biotech Companies

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Medical Imaging & AI-Enhanced Diagnostics Market, By Imaging Modality

  • 5.1 X-Ray Imaging
  • 5.2 Computed Tomography (CT)
  • 5.3 Magnetic Resonance Imaging (MRI)
  • 5.4 Ultrasound Imaging
  • 5.5 Positron Emission Tomography (PET)
  • 5.6 Single Photon Emission Computed Tomography (SPECT)
  • 5.7 Hybrid Imaging

6 Global Medical Imaging & AI-Enhanced Diagnostics Market, By AI Functionality

  • 6.1 Image Acquisition Optimization
  • 6.2 Image Reconstruction & Enhancement
  • 6.3 Computer-Aided Detection (CAD)
  • 6.4 Computer-Aided Diagnosis (CADx)
  • 6.5 Workflow Automation & Triage
  • 6.6 Predictive Analytics & Risk Stratification
  • 6.7 Clinical Decision Support Systems

7 Global Medical Imaging & AI-Enhanced Diagnostics Market, By Deployment Model

  • 7.1 On-Premise Solutions
  • 7.2 Cloud-Based Solutions
  • 7.3 Hybrid Deployment

8 Global Medical Imaging & AI-Enhanced Diagnostics Market, By Application

  • 8.1 Oncology
  • 8.2 Cardiology
  • 8.3 Neurology
  • 8.4 Orthopedics
  • 8.5 Gastroenterology
  • 8.6 Pulmonology
  • 8.7 Obstetrics & Gynecology
  • 8.8 General Radiology

9 Global Medical Imaging & AI-Enhanced Diagnostics Market, By End User

  • 9.1 Hospitals & Clinics
  • 9.2 Diagnostic Imaging Centers
  • 9.3 Research & Academic Institutes
  • 9.4 Pharmaceutical & Biotech Companies

10 Global Medical Imaging & AI-Enhanced Diagnostics Market, By Geography

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
    • 10.1.3 Mexico
  • 10.2 Europe
    • 10.2.1 United Kingdom
    • 10.2.2 Germany
    • 10.2.3 France
    • 10.2.4 Italy
    • 10.2.5 Spain
    • 10.2.6 Netherlands
    • 10.2.7 Belgium
    • 10.2.8 Sweden
    • 10.2.9 Switzerland
    • 10.2.10 Poland
    • 10.2.11 Rest of Europe
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Australia
    • 10.3.6 Indonesia
    • 10.3.7 Thailand
    • 10.3.8 Malaysia
    • 10.3.9 Singapore
    • 10.3.10 Vietnam
    • 10.3.11 Rest of Asia Pacific
  • 10.4 South America
    • 10.4.1 Brazil
    • 10.4.2 Argentina
    • 10.4.3 Colombia
    • 10.4.4 Chile
    • 10.4.5 Peru
    • 10.4.6 Rest of South America
  • 10.5 Rest of the World (RoW)
    • 10.5.1 Middle East
      • 10.5.1.1 Saudi Arabia
      • 10.5.1.2 United Arab Emirates
      • 10.5.1.3 Qatar
      • 10.5.1.4 Israel
      • 10.5.1.5 Rest of Middle East
    • 10.5.2 Africa
      • 10.5.2.1 South Africa
      • 10.5.2.2 Egypt
      • 10.5.2.3 Morocco
      • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

  • 11.1 Industry Value Network and Supply Chain Assessment
  • 11.2 White-Space and Opportunity Mapping
  • 11.3 Product Evolution and Market Life Cycle Analysis
  • 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

  • 12.1 Mergers and Acquisitions
  • 12.2 Partnerships, Alliances, and Joint Ventures
  • 12.3 New Product Launches and Certifications
  • 12.4 Capacity Expansion and Investments
  • 12.5 Other Strategic Initiatives

13 Company Profiles

  • 13.1 GE HealthCare
  • 13.2 Siemens Healthineers
  • 13.3 Koninklijke Philips N.V.
  • 13.4 Canon Medical Systems
  • 13.5 Fujifilm Holdings Corporation
  • 13.6 Hologic, Inc.
  • 13.7 Samsung Medison
  • 13.8 Bracco Imaging S.p.A.
  • 13.9 Aidoc
  • 13.10 Qure.ai
  • 13.11 Viz.ai
  • 13.12 Lunit Inc.
  • 13.13 Tempus Labs
  • 13.14 HeartFlow, Inc.
  • 13.15 Enlitic, Inc.
  • 13.16 Nanox.AI
  • 13.17 Butterfly Network, Inc.
  • 13.18 Riverain Technologies

List of Tables

  • Table 1 Global Medical Imaging & AI-Enhanced Diagnostics Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Medical Imaging & AI-Enhanced Diagnostics Market Outlook, By Imaging Modality (2023-2034) ($MN)
  • Table 3 Global Medical Imaging & AI-Enhanced Diagnostics Market Outlook, By X-Ray Imaging (2023-2034) ($MN)
  • Table 4 Global Medical Imaging & AI-Enhanced Diagnostics Market Outlook, By Computed Tomography (CT) (2023-2034) ($MN)
  • Table 5 Global Medical Imaging & AI-Enhanced Diagnostics Market Outlook, By Magnetic Resonance Imaging (MRI) (2023-2034) ($MN)
  • Table 6 Global Medical Imaging & AI-Enhanced Diagnostics Market Outlook, By Ultrasound Imaging (2023-2034) ($MN)
  • Table 7 Global Medical Imaging & AI-Enhanced Diagnostics Market Outlook, By Positron Emission Tomography (PET) (2023-2034) ($MN)
  • Table 8 Global Medical Imaging & AI-Enhanced Diagnostics Market Outlook, By Single Photon Emission Computed Tomography (SPECT) (2023-2034) ($MN)
  • Table 9 Global Medical Imaging & AI-Enhanced Diagnostics Market Outlook, By Hybrid Imaging (2023-2034) ($MN)
  • Table 10 Global Medical Imaging & AI-Enhanced Diagnostics Market Outlook, By AI Functionality (2023-2034) ($MN)
  • Table 11 Global Medical Imaging & AI-Enhanced Diagnostics Market Outlook, By Image Acquisition Optimization (2023-2034) ($MN)
  • Table 12 Global Medical Imaging & AI-Enhanced Diagnostics Market Outlook, By Image Reconstruction & Enhancement (2023-2034) ($MN)
  • Table 13 Global Medical Imaging & AI-Enhanced Diagnostics Market Outlook, By Computer-Aided Detection (CAD) (2023-2034) ($MN)
  • Table 14 Global Medical Imaging & AI-Enhanced Diagnostics Market Outlook, By Computer-Aided Diagnosis (CADx) (2023-2034) ($MN)
  • Table 15 Global Medical Imaging & AI-Enhanced Diagnostics Market Outlook, By Workflow Automation & Triage (2023-2034) ($MN)
  • Table 16 Global Medical Imaging & AI-Enhanced Diagnostics Market Outlook, By Predictive Analytics & Risk Stratification (2023-2034) ($MN)
  • Table 17 Global Medical Imaging & AI-Enhanced Diagnostics Market Outlook, By Clinical Decision Support Systems (2023-2034) ($MN)
  • Table 18 Global Medical Imaging & AI-Enhanced Diagnostics Market Outlook, By Deployment Model (2023-2034) ($MN)
  • Table 19 Global Medical Imaging & AI-Enhanced Diagnostics Market Outlook, By On-Premise Solutions (2023-2034) ($MN)
  • Table 20 Global Medical Imaging & AI-Enhanced Diagnostics Market Outlook, By Cloud-Based Solutions (2023-2034) ($MN)
  • Table 21 Global Medical Imaging & AI-Enhanced Diagnostics Market Outlook, By Hybrid Deployment (2023-2034) ($MN)
  • Table 22 Global Medical Imaging & AI-Enhanced Diagnostics Market Outlook, By Application (2023-2034) ($MN)
  • Table 23 Global Medical Imaging & AI-Enhanced Diagnostics Market Outlook, By Oncology (2023-2034) ($MN)
  • Table 24 Global Medical Imaging & AI-Enhanced Diagnostics Market Outlook, By Cardiology (2023-2034) ($MN)
  • Table 25 Global Medical Imaging & AI-Enhanced Diagnostics Market Outlook, By Neurology (2023-2034) ($MN)
  • Table 26 Global Medical Imaging & AI-Enhanced Diagnostics Market Outlook, By Orthopedics (2023-2034) ($MN)
  • Table 27 Global Medical Imaging & AI-Enhanced Diagnostics Market Outlook, By Gastroenterology (2023-2034) ($MN)
  • Table 28 Global Medical Imaging & AI-Enhanced Diagnostics Market Outlook, By Pulmonology (2023-2034) ($MN)
  • Table 29 Global Medical Imaging & AI-Enhanced Diagnostics Market Outlook, By Obstetrics & Gynecology (2023-2034) ($MN)
  • Table 30 Global Medical Imaging & AI-Enhanced Diagnostics Market Outlook, By General Radiology (2023-2034) ($MN)
  • Table 31 Global Medical Imaging & AI-Enhanced Diagnostics Market Outlook, By End User (2023-2034) ($MN)
  • Table 32 Global Medical Imaging & AI-Enhanced Diagnostics Market Outlook, By Hospitals & Clinics (2023-2034) ($MN)
  • Table 33 Global Medical Imaging & AI-Enhanced Diagnostics Market Outlook, By Diagnostic Imaging Centers (2023-2034) ($MN)
  • Table 34 Global Medical Imaging & AI-Enhanced Diagnostics Market Outlook, By Research & Academic Institutes (2023-2034) ($MN)
  • Table 35 Global Medical Imaging & AI-Enhanced Diagnostics Market Outlook, By Pharmaceutical & Biotech Companies (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.